Overview

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Status:
Terminated

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

This research study is evaluating the use of radiation therapy in combination with chemotherapy as a possible treatment for intrahepatic cholangiocarcinoma, a rare form of gastrointestinal cancer.

Phase:

N/A

Details

Lead Sponsor:

Massachusetts General Hospital

Treatments:

Cisplatin
Gemcitabine